Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07550764 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Infrared-Assisted Intravenous Catheterization on Patient Comfort in Lung Cancer Patients

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: 3 to 1
    • Secondary endpoints expanded, about 22 words
    • Study description expanded, about 206 words
    • Study title shortened, about 3 words
  2. Primary endpoint(s) modified Show 7 more changesShow less
    • Start date: Nov 1, 2025 to Apr 1, 2026
    • Trial completed
    • Primary completion date changed from estimate of Aug 1, 2026 to Aug 31, 2026
    • Interventions modified
    • Eligibility criteria expanded, about 128 words
    • Study description expanded, about 551 words
    • Study site revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study evaluated the effect of near-infrared (NIR) vein visualization-assisted peripheral intravenous catheterization on procedure-specific patient comfort and procedural pain in adults with lung cancer receiving outpatient chemotherapy. Patients receiving chemotherapy often develop progressive venous damage, which can make peripheral intravenous catheterization difficult. Failed attempts may increase pain and discomfort. The study used an explanatory sequential mixed-methods design (QUAN→qual). In the quantitative phase, 160 patients were randomized 1:1 to NIR-assisted catheterization or to standard catheterization based on visual inspection and palpation. In the qualitative phase, semi-structured individual interviews were conducted with 11 patients from the intervention group to explore their experiences with the NIR device. The study was conducted at the Outpatient Chemotherapy Unit of Ataturk University Research Hospital, Erzurum, Turkey, as part of a doctoral thesis in Fundamentals of Nursing.
Trial Details
NCT Number NCT07550764
Lead Sponsor Ataturk University
Collaborators: Atatürk University Scientific Research Projects Coordination Unit
Conditions
(from sponsor)		 Lung Cancer (Diagnosis)
Related terms Disease, Lung Neoplasms
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov